Interview with the President and CEO: Valeritas, Inc. (OTCMKTS:VLRX)

Healthcare >> CEO Interviews >> July 29, 2016

John Timberlake has served as President, Chief Executive Officer and as a member of the board of directors of Valeritas, Inc., since February 2016. He additionally held the roles of President and Chief Commercial Officer of Valeritas beginning in August 2008, and General Manager from September 2006. Prior to joining Valeritas, Mr. Timberlake held positions of increasing responsibility from 1991 to 2006 at Sanofi-Aventis — now Sanofi — with his last role as Vice President of Diabetes Marketing, where he was responsible for the diabetes franchise, including the brands Lantus, Apidra and Amaryl. While at Sanofi, Mr. Timberlake had extensive experience and commercial responsibilities for new products in development across multiple therapeutic areas, including inhaled insulin and other metabolic products. Before working in the health care industry, Mr. Timberlake was a manager with Deloitte & Touche LLP from 1986 to 1991, and was both a certified management accountant and a certified public accountant. He earned a B.S. in accounting at Northwest Missouri State University, an M.S. in management from Purdue University and an MBA from ESC Rouen in France — now NEOMA Business School. Profile

TWST: Can you describe Valeritas, and talk about its core technology and how it differs from the current standard of care?

Mr. Timberlake: Valeritas is a

Join for free to read a longer excerpt or purchase this article

Interview with the President and CEO: Valeritas, Inc. (OTCMKTS:VLRX)

Top Company Interviews

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS

Interview with the President and CEO: Valeritas, Inc. (OTCMKTS:VLRX)

Top Company Interviews

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS